Please ensure Javascript is enabled for purposes of website accessibility
REVIEW PAPER
Myocardial infarction with non-obstructive coronary arteries
 
More details
Hide details
 
Submission date: 2018-10-12
 
 
Acceptance date: 2018-11-22
 
 
Publication date: 2018-12-31
 
 
Medical Studies 2018;34(4):332-336
 
KEYWORDS
TOPICS
ABSTRACT
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a working diagnosis in about 10% of cases presenting with symptoms suggestive of acute myocardial ischaemia and no significant atherosclerotic plaques in coronary angiography. It is a heterogenous clinical entity with a complex aetiology and always requires a challenging work-up. The final diagnosis may confirm any coronary pathology (dissection, spasm, thrombus) or significantly differ from the previous one (myocarditis, takotsubo cardiomyopathy). This paper focuses on the current knowledge on MINOCA, guidelines on the management of patients, and indicates new research areas to further elucidate this issue. The most important message is that MINOCA is a serious condition with outcomes at least as serious as in myocardial infarction resulting from coronary atherosclerosis.
REFERENCES (21)
1.
Ibanez B, James S, Agewall S, Antunes MJ, BucciarelliDucci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119-77.
 
2.
DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.
 
3.
Beltrame JF. Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA). J Intern Med 2013; 273: 182-5.
 
4.
Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 2017; 38: 143-53.
 
5.
Pasupathy S, Tavella R, Beltrame JF. Myocardial infarction with nonobstructive coronary arteries (MINOCA): the past, present, and future management. Circulation 2017; 135: 1490-3.
 
6.
McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, Patel A, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry. Arch Intern Med 2012; 172: 864-71.
 
7.
Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, Fischer C, DeMaria AN. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991; 84: 1087-99.
 
8.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2018; doi: 10.1093/eurheartj/ehy462. [Epub ahead of print].
 
9.
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267-315.
 
10.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39: 3165-241.
 
11.
Zachura M, Piątek Ł, Kurzawski J, Janion M. Coronary embolism causing acute myocardial infarction. Review of the literature. Medical Studies 2016; 32: 131-5.
 
12.
Safdar B, Spatz ES, Dreyer RP, Beltrame JF, Lichtman JH, Spertus JA, Reynolds HR, Geda M, Bueno H, Dziura JD, Krumholz HM, D’Onofrio G. Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study. J Am Heart Assoc 2018; 7. pii: e009174.
 
13.
Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 2015; 131: 861-70.
 
14.
Reynolds HR, Srichai MB, Iqbal SN, Slater JN, Mancini GB, Feit F, Pena-Sing I, Axel L, Attubato MJ, Yatskar L, Kalhorn RT, Wood DA, Lobach IV, Hochman JS. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011; 124: 1414-25.
 
15.
Pathik B, Raman B, Mohd Amin NH, Mahadavan D, Rajendran S, McGavigan AD, Grover S, Smith E, Mazhar J, Bridgman C, Ganesan AN, Selvanayagam JB. Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2016; 17: 1146-52.
 
16.
Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskjöld A, Gard A, Jernberg T. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation 2017; 135: 1481-9.
 
17.
https://clinicaltrials.gov/ct2... (Accessed October, 12, 2018).
 
18.
Nordenskjöld AM, Baron T, Eggers KM, Jernberg T, Lindahl B. Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery (MINOCA) disease. Int J Cardiol 2018; 261: 18-23.
 
19.
Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, Ohman EM, Newby LK, Peterson ED, Hochman JS. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009; 158: 688-94.
 
20.
Nordenskjold AM, Lagerqvist B, Baron T, Jernberg T, Tornvall P, Lindahl B. Reinfarction in patients with previous myocardial infarction with nonobstructive coronary arteries (MINOCA), findings at coronary angiography. Eur Heart J 2018; 39 Suppl 1: 1256.
 
21.
Tavella R, Pasupathy S, Beltrame JF. MINOCA – a personalised medicine approach. Int J Cardiol 2018; 267: 54-5.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top